About ApaTech
ApaTech is a Healthcare company based in Elstree (United Kingdom) founded in 2001 by Philip William Morgan and Professor William Bonfield, and was acquired by Baxter in March 2010. Synthetic bone repair materials are developed for orthopedic uses. ApaTech has raised $56.51 million across 2 funding rounds from investors including Baxter, 3i Group and HealthCor Partners. The company has 43 employees. ApaTech was last valued at $14.79 million in April 2004. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is APATECH LIMITED.
Company details
ApaTech was founded in 2001 and is based in Elstree, United Kingdom, within the ortho-biologics sector. Synthetic bone graft materials are produced, including Actifuse for promoting bone formation in small voids and spinal fusions, ApaPore as a porous hydroxyapatite for joint revisions, fracture fixations, and bone defects, and a delivery system for minimally invasive procedures. Products are distributed through partners in Europe and Australia.
- Headquarters Elstree, United Kingdom
- Employees 43
- Founders Philip William Morgan, Professor William Bonfield
- Stage Acquired
- SectorsHealthcare
- Website apatech.com
- Social LinkedIn
- Acquired by Baxter (Mar 2010)
- Legal Name Apatech Limited
- Date of Incorporation 01 Mar, 2001
- Jurisdiction ELSTREE, HERTFORDSHIRE, ENGLAND
Funding Insights of ApaTech
ApaTech has successfully raised a total of $56.51M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $45 million completed in June 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $56.51M
- Total Rounds 2
- Last Round Series B — $45M
- First Round $11.51M
(Apr 2004)
- Investors Count 3
All 2 funding rounds of ApaTech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2008 | $45M | Series B | – | HealthCor Partners, 3i Group | – |
| Apr 2004 | $11.51M | Series B | $14.79M | MTI Partners, 3i Group | – |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2004 | $14.79M | •••••••• |
Last known valuation $14.79M (Apr 2004). 4 investors in total: 4 institutional.
Investors in ApaTech
ApaTech has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Baxter, 3i Group and HealthCor Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| healthcorpartners.com | ||||
Private equity firm focused on mid-market businesses | 1945 | 3i.com | London, United Kingdom | |
| mtiventures.com | ||||
Biosciences, medication delivery, and renal products are developed and marketed. | 1931 | baxter.com | Deerfield, United States |
Investor details for ApaTech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ApaTech
2 people are tracked at ApaTech (2 in leadership); the tracked headcount is 43.
| Name | Role | Group |
|---|---|---|
Philip William Morgan | Co-Founder | Leadership |
Professor William Bonfield | Co-Founder | Leadership |
Complete people profiles for ApaTech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ApaTech
5 dated milestones of ApaTech across 9 years, from founding to its latest funding, stage changes and deals.
- Founded ApaTech is founded.
- Funding First funding round of $11.5M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series B, of $45.0M.
- Exit Acquired by Baxter.
Web traffic of ApaTech
Websites that share an audience with ApaTech (apatech.com).
Websites whose visitors overlap most with ApaTech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| affymetrix.com | 100% | 1.1K | #9,164,392 | View details | |
isispharm.com | isispharm.com | 100% | – | ||
| baxter.com | 52% | 401.8K | #127,908 | View details | |
n-forcefixation.com | n-forcefixation.com | 39% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Apatech
Complete news archive for ApaTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ApaTech
ApaTech was founded in 2001 and raised its 1st funding round 3 years after it was founded.
ApaTech is headquartered in Elstree, United Kingdom. It is registered at Elstree, Hertfordshire, United Kingdom.
ApaTech is a funded company, having raised a total of $56.51M across 2 funding rounds to date. The company's 1st funding round was a Series B of $11.51M, raised on Apr 2004.
ApaTech has 43 employees.
Annual revenue of ApaTech is $20.47M as on Dec 31, 2016.
ApaTech was founded in 2001 and is based in Elstree, United Kingdom, within the ortho-biologics sector. Synthetic bone graft materials are produced, including Actifuse for promoting bone formation in small voids and spinal fusions, ApaPore as a porous hydroxyapatite for joint revisions, fracture fixations, and bone defects, and a delivery system for minimally invasive procedures. Products are distributed through partners in Europe and Australia.
The valuation of ApaTech is $14.79M as of Apr 2004.
ApaTech operates through Apatech Limited.
Yes. ApaTech was acquired by Baxter in March 2010.